Fortress Biotech, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Fortress Biotech, Inc. (FBIO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 540.00 thousand shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2025-03-31
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-12-31 was 0.00 shares.
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-09-30 was 0.00 shares.
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-06-30 was 0.00 shares.
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-03-31 was 540.00K shares.
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 540.00K shares.
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 2.00M shares.
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2019 was 125.00K shares.
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2017 was 1.90M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|---|
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 0.00 shares derived: sum of 2 quarters · filed 2025-03-31 | 0.00 shares derived: sum of 3 quarters · filed 2025-03-31 | 540.00K shares 10-K · filed 2025-03-31 | ||
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-14 | 540.00K shares 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 540.00K shares 10-Q · filed 2024-08-13 | ||||
| 2024-03-31 | 540.00K shares 10-Q · filed 2024-05-15 | |||||
| 2022-12-31 | 2.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 2.00M shares derived: sum of 2 quarters · filed 2023-03-31 | 2.00M shares derived: sum of 3 quarters · filed 2023-03-31 | 2.00M shares 10-K · filed 2023-03-31 | ||
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2022-11-14 | 2.50K shares 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 2.50K shares 10-Q · filed 2022-08-11 | ||||
| 2022-03-31 | 2.50K shares 10-Q · filed 2022-05-12 | |||||
| 2020-09-30 | 100.00K shares 10-Q · filed 2020-11-09 | |||||
| 2019-12-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-09 | 0.00 shares derived: sum of 2 quarters · filed 2021-04-09 | 125.00K shares 10-K/A · filed 2021-04-09 | |||
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 125.00K shares 10-Q · filed 2019-11-12 | ||||
| 2019-06-30 | 125.00K shares 10-Q · filed 2019-08-09 | |||||
| 2017-12-31 | 1.90M shares 10-K · filed 2019-03-18 | |||||
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | 0.00 shares derived: sum of 2 quarters · filed 2016-11-09 | 0.00 shares 10-Q · filed 2016-11-09 | 0.00 shares derived: sum of 4 quarters · filed 2016-11-09 | ||
| 2016-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | 0.00 shares 10-Q · filed 2016-08-09 | 0.00 shares derived: sum of 3 quarters · filed 2016-08-09 | 0.00 shares derived: sum of 4 quarters · filed 2016-08-09 | ||
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-10 | 0.00 shares derived: sum of 2 quarters · filed 2016-05-10 | 0.00 shares derived: sum of 3 quarters · filed 2016-05-10 | -1.50M shares derived: sum of 4 quarters · filed 2016-05-10 | ||
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | 0.00 shares derived: sum of 2 quarters · filed 2016-03-15 | -1.50M shares derived: sum of 3 quarters · filed 2016-03-15 | 0.00 shares 10-K · filed 2016-03-15 | ||
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -1.50M shares derived: sum of 2 quarters · filed 2015-11-09 | 0.00 shares 10-Q · filed 2015-11-09 | 0.00 shares derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-07-15 | 50.00K shares 10-K · filed 2017-03-16 | |||||
| 2015-06-30 | -1.50M shares derived: 10-Q 6 month − 10-K 3 month · filed 2015-08-10 | 0.00 shares 10-Q · filed 2015-08-10 | 0.00 shares derived: sum of 3 quarters · filed 2017-03-16 | 0.00 shares derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-03-31 | 1.50M shares 10-K · filed 2017-03-16 | 0.00 shares 10-Q · filed 2015-05-11 | 1.50M shares derived: sum of 2 quarters · filed 2017-03-16 | 1.50M shares derived: sum of 3 quarters · filed 2017-03-16 | 1.50M shares derived: sum of 4 quarters · filed 2017-03-16 | |
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | 0.00 shares derived: sum of 2 quarters · filed 2015-03-16 | 0.00 shares derived: sum of 3 quarters · filed 2015-03-16 | 0.00 shares 10-K · filed 2015-03-16 | ||
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | 0.00 shares derived: sum of 2 quarters · filed 2014-11-06 | 0.00 shares 10-Q · filed 2014-11-06 | 435.00K shares derived: sum of 4 quarters · filed 2014-11-06 | ||
| 2014-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | 0.00 shares 10-Q · filed 2014-08-11 | 435.00K shares derived: sum of 3 quarters · filed 2014-08-11 | 435.00K shares derived: sum of 4 quarters · filed 2014-08-11 | ||
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-12 | 435.00K shares derived: sum of 2 quarters · filed 2014-05-12 | 435.00K shares derived: sum of 3 quarters · filed 2014-05-12 | 695.00K shares derived: sum of 4 quarters · filed 2014-05-12 | ||
| 2013-12-31 | 435.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | 435.00K shares derived: sum of 2 quarters · filed 2014-03-14 | 695.00K shares derived: sum of 3 quarters · filed 2014-03-14 | 2.47M shares 10-K · filed 2014-03-14 | ||
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | 260.00K shares derived: sum of 2 quarters · filed 2013-11-01 | 2.03M shares 10-Q · filed 2013-11-01 | 2.14M shares derived: sum of 4 quarters · filed 2013-11-01 | ||
| 2013-06-30 | 260.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | 2.03M shares 10-Q · filed 2013-08-05 | 2.14M shares derived: sum of 3 quarters · filed 2013-08-05 | 2.22M shares derived: sum of 4 quarters · filed 2013-08-05 | ||
| 2013-03-31 | 1.77M shares 10-Q · filed 2013-05-09 | 1.88M shares derived: sum of 2 quarters · filed 2013-05-09 | 1.96M shares derived: sum of 3 quarters · filed 2013-05-09 | |||
| 2012-12-31 | 110.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | 190.00K shares derived: sum of 2 quarters · filed 2013-03-18 | 730.00K shares 10-K · filed 2013-03-18 | |||
| 2012-09-30 | 80.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | 620.00K shares 10-Q · filed 2012-11-14 | ||||
| 2012-06-30 | 540.00K shares 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |